293 related articles for article (PubMed ID: 22198637)
1. ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer.
Mazzoccoli G; Pazienza V; Panza A; Valvano MR; Benegiamo G; Vinciguerra M; Andriulli A; Piepoli A
J Cancer Res Clin Oncol; 2012 Mar; 138(3):501-11. PubMed ID: 22198637
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.
Hazelbag S; Kenter GG; Gorter A; Fleuren GJ
Int J Cancer; 2004 Dec; 112(6):1020-8. PubMed ID: 15386352
[TBL] [Abstract][Full Text] [Related]
3. Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer.
Kim JH; Cho NY; Bae JM; Kim KJ; Rhee YY; Lee HS; Kang GH
Int J Clin Exp Pathol; 2015; 8(2):1920-8. PubMed ID: 25973084
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of microsatellite instability in T1 colorectal cancer.
Kang J; Lee HW; Kim IK; Kim NK; Sohn SK; Lee KY
Yonsei Med J; 2015 Jan; 56(1):175-81. PubMed ID: 25510762
[TBL] [Abstract][Full Text] [Related]
5. Expression of urokinase-type plasminogen activator receptor and plasminogen activator inhibitor-1 in gastric cancer.
Kawasaki K; Hayashi Y; Wang Y; Suzuki S; Morita Y; Nakamura T; Narita K; Doe W; Itoh H; Kuroda Y
J Gastroenterol Hepatol; 1998 Sep; 13(9):936-44. PubMed ID: 9794194
[TBL] [Abstract][Full Text] [Related]
6. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 as a prognostic factor in human colorectal carcinomas.
Fujii T; Obara T; Tanno S; Ura H; Kohgo Y
Hepatogastroenterology; 1999; 46(28):2299-308. PubMed ID: 10521987
[TBL] [Abstract][Full Text] [Related]
8. Antigen levels of urokinase plasminogen activator and its receptor at the tumor-host interface of colorectal adenocarcinomas are related to tumor aggressiveness.
Buø L; Meling GI; Karlsrud TS; Johansen HT; Aasen AO
Hum Pathol; 1995 Oct; 26(10):1133-8. PubMed ID: 7557947
[TBL] [Abstract][Full Text] [Related]
9. CD133 mRNA expression and microsatellite instability in colorectal carcinoma.
Huh JW; Park YS; Lee JH; Kim HR; Shin MG; Kim YJ
J Surg Oncol; 2010 Dec; 102(7):765-70. PubMed ID: 20872808
[TBL] [Abstract][Full Text] [Related]
10. NAMPT, GRN, and SERPINE1 signature as predictor of disease progression and survival in gliomas.
Vachher M; Arora K; Burman A; Kumar B
J Cell Biochem; 2020 Apr; 121(4):3010-3023. PubMed ID: 31710121
[TBL] [Abstract][Full Text] [Related]
11. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.
Koensgen D; Mustea A; Klaman I; Sun P; Zafrakas M; Lichtenegger W; Denkert C; Dahl E; Sehouli J
Gynecol Oncol; 2007 Nov; 107(2):266-73. PubMed ID: 17698176
[TBL] [Abstract][Full Text] [Related]
12. Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse.
Harbeck N; Thomssen C; Berger U; Ulm K; Kates RE; Höfler H; Jänicke F; Graeff H; Schmitt M
Breast Cancer Res Treat; 1999 Mar; 54(2):147-57. PubMed ID: 10424405
[TBL] [Abstract][Full Text] [Related]
13. Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size.
Abe J; Urano T; Konno H; Erhan Y; Tanaka T; Nishino N; Takada A; Nakamura S
Cancer; 1999 Dec; 86(12):2602-11. PubMed ID: 10594855
[TBL] [Abstract][Full Text] [Related]
14. The circadian rhythm key gene
Wu G; Ren H; Hu Q; Ma H; Chen H; Zhou L; Xu K; Ding L
Front Immunol; 2023; 14():1115809. PubMed ID: 37275880
[TBL] [Abstract][Full Text] [Related]
15. ZEB1 Promotes invasiveness of colorectal carcinoma cells through the opposing regulation of uPA and PAI-1.
Sánchez-Tilló E; de Barrios O; Siles L; Amendola PG; Darling DS; Cuatrecasas M; Castells A; Postigo A
Clin Cancer Res; 2013 Mar; 19(5):1071-82. PubMed ID: 23340304
[TBL] [Abstract][Full Text] [Related]
16. Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.
Herszényi L; Farinati F; Cardin R; István G; Molnár LD; Hritz I; De Paoli M; Plebani M; Tulassay Z
BMC Cancer; 2008 Jul; 8():194. PubMed ID: 18616803
[TBL] [Abstract][Full Text] [Related]
17. Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers.
Nakata S; Ito K; Fujimori M; Shingu K; Kajikawa S; Adachi W; Matsuyama I; Tsuchiya S; Kuwano M; Amano J
Int J Cancer; 1998 Apr; 79(2):179-86. PubMed ID: 9583734
[TBL] [Abstract][Full Text] [Related]
18. Elevated microsatellite alterations at selected tetranucleotides in early-stage colorectal cancers with and without high-frequency microsatellite instability: same, same but different?
Watson MM; Lea D; Rewcastle E; Hagland HR; Søreide K
Cancer Med; 2016 Jul; 5(7):1580-7. PubMed ID: 27061136
[TBL] [Abstract][Full Text] [Related]
19. Mismatch repair system and p53 expression in patients with T1 and T2 colorectal cancer: predictive role of lymph node metastasis and survival.
Huh JW; Kim HC; Kim SH; Park YA; Cho YB; Yun SH; Lee WY; Chun HK
J Surg Oncol; 2014 Jun; 109(8):848-52. PubMed ID: 24623275
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor D is associated with lymph node metastasis in human colorectal carcinoma.
Funaki H; Nishimura G; Harada S; Ninomiya I; Terada I; Fushida S; Tani T; Fujimura T; Kayahara M; Shimizu K; Ohta T; Miwa K
Oncology; 2003; 64(4):416-22. PubMed ID: 12759540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
